MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.
Stryker
Covidien touts FDA clearance for “game-changing” Solitaire revascularization device
Covidien plc (NYSE:COV) won FDA clearance for its Solitaire FR revascularization device for removing blood clots and restoring blood flow in the brains of patients suffering acute ischemic stroke.
The federal watchdog agency cleared the device, which physically removes blood clots from vessels, on the basis of data gathered during Covidien’s Swift study, the first of its kind to compare mechanical interventions for acute ischemic stroke, according to a press release.
MassDevice.com +7 | The top 7 med-tech stories for the week of February 27, 2012.
Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you’re still in the know with MassDevice +7.
MassDevice.com +3 | The top 3 med-tech stories for March 2, 2012.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
St. Jude and Stryker tie for most admired company for 2012 | MassDevice.com On Call
MassDevice.com +3 | The top 3 med-tech stories for February 28, 2012.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Stryker CEO: Rumors swirl over MacMillan’s departure
Former Stryker (NYSE:SYK) CEO Stephen MacMillan’s departure from the company may have come as the result of an extramarital affair with a former company employee, according to a report in the Wall Street Journal.
Buffett may back out of J&J | MassDevice.com On Call
MASSDEVICE ON CALL — Investment tycoon Warren Buffet may be ready to ditch his stake in Johnson & Johnson (NYSE:JNJ), he said during a CNBC interview.
J&J has "obviously has messed up in a lot of ways in the last few years," the chairman & CEO of Berkshire Hathaway (NYSE:BRK.A) said, referring to a slew of company recalls covering a range of products from hip implants to baby lotion.
Ex-Stryker CEO Stephen MacMillan walks away with millions in severance and stock options
Stryker Corp. (NYSE:SYK) and former CEO Stephen MacMillan agreed to a separation agreement that will immediately pay him $5.5 million in cash, plus the rights to purchase up to $65 million worth of company stock, among other perks.
In filings with the federal Securities & Exchange Commission, the company said MacMillan will "receive a payment of $5,500,000 on or about February 29, 2012."
Will Advanced BioHealing pay off for Shire with a buyout deal? | Wall Street Beat
Buyout chatter pushed shares of Shire plc (FTSE:SHP) up nearly 2% in London yesterday and added 1.4% on Wall Street.
Stryker ex-CEO MacMillan resigns from Texas Instruments board | Personnel Moves
Following his abrupt resignation from the corner office at Stryker Corp. (NYSE:SYK), Stephen MacMillan also stepped down from the Texas Instruments board of directors.
MacMillan had been on the board since 2008. No reason was given for his departure in regulatory filings.